Skip to main content

Kim Ekroos, PhD

CEO and Founder at Lipidomics Consulting Ltd.

Location: Esbo Finland

Dr. Kim Ekroos is one of the pioneers in the field of lipidomics. He obtained his PhD in biology from the Technical University in Dresden, Germany, in 2003. In 2004, he started his postdoctoral work at the department of DMPK & bioanalytical chemistry at AstraZeneca in Mölndal, Sweden. In 2008, he joined Zora Biosciences Oy and became chief technology officer in 2013. In 2016, he founded Lipidomics Consulting Ltd., a consulting business providing unique services for customers globally by designing conclusive mass spectrometry (MS) and experimental approaches to make inroads into cell, disease, biomarker and drug research and development. Today, he is the president of the International Lipidomics Society (ILS; and spearheading the Lipidomics Standardization Initiative.

Associated Grants

  • Characterizing Region-specific Lipid Profiles in Parkinson’s Disease and Gaucher Disease


  • More Than Pretty Pictures: Ion Imaging of Lipid Content and Flux Kinetics in Models of Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.